MedTrace Logo

An Observational Study of OPTIVE PLUS® for the Treatment of Dry Eye Disease

NCT01711424 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1209

Last updated 2014-03-17

Study results available
· View outcomes & findings →

Summary

This is an observational study of OPTIVE PLUS® in patients with dry eye disease in a routine clinical setting. Treatment decisions are made by the physician and reflect the physician's current standard of care.

Conditions

  • Dry Eye Syndromes

Interventions

DRUG

OPTIVE PLUS®

Patients with dry eye prescribed OPTIVE PLUS® in accordance with physician standard practice.

Sponsors & Collaborators

  • Allergan

    lead INDUSTRY

Principal Investigators

  • Medical Director · Allergan

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01711424 on ClinicalTrials.gov